Gwenn Hansen - Chief Scientific Officer at Nurix Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Scientific Officer
Issuer Symbol
NRIX on Nasdaq
All Insider Reports
All Insider Reports

Gwenn Hansen - trading volume in the past year for Nurix Therapeutics, Inc.

Holdings reported by Gwenn Hansen for Nurix Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Restricted Stock Units 42,875 $702,464 $20.48 10 Feb 2026 Direct Common Stock
Common Stock 115,005 $96,604 $0.8400 03 Feb 2026 Direct
Employee Stock Option (right to buy) 93,750 10 Feb 2026 Direct Common Stock

Transactions reported by Gwenn Hansen for Nurix Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.